TY - JOUR
T1 - Assisted peritoneal dialysis in Europe
T2 - a strategy to increase and maintain home dialysis
AU - Reyskens, Margot
AU - Abrahams, Alferso C.
AU - François, Karlien
AU - Van Eck Van Der Sluijs, Anita
N1 - Funding Information:
This paper was published as part of a supplement financially supported by Baxter Healthcare.
Funding Information:
M.R. has no financial interests to disclose. A.C.A. received speaker fees from Baxter Healthcare and Fresenius Medical Care, and research grants from Baxter Healthcare and the Dutch Kidney Foundation. K.F. received speaker fees and an investigator-initiated research grant from Baxter Healthcare. A.E.S. received speaker fees from Baxter Healthcare. A.C.A., K.F. and A.E.S. have no other financial interests related to this article
Publisher Copyright:
© 2024 The Author(s). Published by Oxford University Press on behalf of the ERA.
© The Author(s) 2024. Published by Oxford University Press on behalf of the ERA.
PY - 2024/5/1
Y1 - 2024/5/1
N2 - Peritoneal dialysis (PD) is a form of kidney replacement therapy with the major advantage that it can be performed at home. This has a positive impact on patients' autonomy and quality of life. However, the dialysis population is ageing and physical and/or cognitive impairments are common. These limitations often form a barrier to PD and contribute to the low incidence and prevalence of PD in Europe. Assisted PD can be a solution to this problem. Assisted PD refers to a patient being assisted by a person or device in performing all or part of their dialysis-related tasks, thereby making PD more accessible to elderly but also younger frail patients. In this way, offering an assisted PD program can help lower the threshold for initiating PD. In this review, we provide an overview of the epidemiology of assisted PD in Europe, we discuss the different categories and clinical outcomes of assisted PD, and we present how assisted PD can be implemented in clinical practice as a possible strategy to increase and maintain home dialysis in Europe.
AB - Peritoneal dialysis (PD) is a form of kidney replacement therapy with the major advantage that it can be performed at home. This has a positive impact on patients' autonomy and quality of life. However, the dialysis population is ageing and physical and/or cognitive impairments are common. These limitations often form a barrier to PD and contribute to the low incidence and prevalence of PD in Europe. Assisted PD can be a solution to this problem. Assisted PD refers to a patient being assisted by a person or device in performing all or part of their dialysis-related tasks, thereby making PD more accessible to elderly but also younger frail patients. In this way, offering an assisted PD program can help lower the threshold for initiating PD. In this review, we provide an overview of the epidemiology of assisted PD in Europe, we discuss the different categories and clinical outcomes of assisted PD, and we present how assisted PD can be implemented in clinical practice as a possible strategy to increase and maintain home dialysis in Europe.
KW - assisted peritoneal dialysis
KW - device-assisted
KW - home dialysis
KW - informal caregiver
KW - kidney replacement therapy
UR - http://www.scopus.com/inward/record.url?scp=85195454336&partnerID=8YFLogxK
U2 - 10.1093/ckj/sfae078
DO - 10.1093/ckj/sfae078
M3 - Article
C2 - 38846415
AN - SCOPUS:85195454336
SN - 2048-8505
VL - 17
SP - i34-i43
JO - Clinical Kidney Journal
JF - Clinical Kidney Journal
IS - Suppl 1
ER -